These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 21788139
1. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads. Habash M, Taha MO. Bioorg Med Chem; 2011 Aug 15; 19(16):4746-71. PubMed ID: 21788139 [Abstract] [Full Text] [Related]
2. Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay. Al-Sha'er MA, Taha MO. Eur J Med Chem; 2010 Sep 15; 45(9):4316-30. PubMed ID: 20638755 [Abstract] [Full Text] [Related]
3. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases. Zhang L, Chen J, Gong Y, Liu J, Zhang L, Hua W, Sun H. Chem Biodivers; 2009 Jun 15; 6(6):864-74. PubMed ID: 19551727 [Abstract] [Full Text] [Related]
4. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration. Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO. Eur J Med Chem; 2010 Apr 15; 45(4):1598-617. PubMed ID: 20116902 [Abstract] [Full Text] [Related]
6. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site. Kristiansen M, Andersen B, Iversen LF, Westergaard N. J Med Chem; 2004 Jul 01; 47(14):3537-45. PubMed ID: 15214781 [Abstract] [Full Text] [Related]
7. Structural investigations of anthranilimide derivatives by CoMFA and CoMSIA 3D-QSAR studies reveal novel insight into their structures toward glycogen phosphorylase inhibition. Saqib U, Kumar B, Siddiqi MI. SAR QSAR Environ Res; 2011 Jul 01; 22(5-6):411-49. PubMed ID: 21607894 [Abstract] [Full Text] [Related]
8. Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies. Taha MO, Habash M, Al-Hadidi Z, Al-Bakri A, Younis K, Sisan S. J Chem Inf Model; 2011 Mar 28; 51(3):647-69. PubMed ID: 21370899 [Abstract] [Full Text] [Related]
9. Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors. Dudash J, Zhang Y, Moore JB, Look R, Liang Y, Beavers MP, Conway BR, Rybczynski PJ, Demarest KT. Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4790-3. PubMed ID: 16143521 [Abstract] [Full Text] [Related]
10. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors. Abu Hammad AM, Taha MO. J Chem Inf Model; 2009 Apr 01; 49(4):978-96. PubMed ID: 19341295 [Abstract] [Full Text] [Related]
11. 3'-axial CH2 OH substitution on glucopyranose does not increase glycogen phosphorylase inhibitory potency. QM/MM-PBSA calculations suggest why. Manta S, Xipnitou A, Kiritsis C, Kantsadi AL, Hayes JM, Skamnaki VT, Lamprakis C, Kontou M, Zoumpoulakis P, Zographos SE, Leonidas DD, Komiotis D. Chem Biol Drug Des; 2012 May 01; 79(5):663-73. PubMed ID: 22296957 [Abstract] [Full Text] [Related]
12. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase. Zhang L, Chen X, Liu J, Zhu Q, Leng Y, Luo X, Jiang H, Liu H. Eur J Med Chem; 2012 Dec 01; 58():624-39. PubMed ID: 23178962 [Abstract] [Full Text] [Related]
13. Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase. Zhu P, Bi Y, Xu J, Li Z, Liu J, Zhang L, Ye W, Wu X. Bioorg Med Chem Lett; 2009 Dec 15; 19(24):6966-9. PubMed ID: 19889536 [Abstract] [Full Text] [Related]
14. Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. Taha MO, Dahabiyeh LA, Bustanji Y, Zalloum H, Saleh S. J Med Chem; 2008 Oct 23; 51(20):6478-94. PubMed ID: 18808096 [Abstract] [Full Text] [Related]
15. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Onda K, Shiraki R, Ogiyama T, Yokoyama K, Momose K, Katayama N, Orita M, Yamaguchi T, Furutani M, Hamada N, Takeuchi M, Okada M, Ohta M, Tsukamoto S. Bioorg Med Chem; 2008 Dec 01; 16(23):10001-12. PubMed ID: 18952447 [Abstract] [Full Text] [Related]
17. Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads. Shahin R, Taha MO. Bioorg Med Chem; 2012 Jan 01; 20(1):377-400. PubMed ID: 22112539 [Abstract] [Full Text] [Related]
19. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase. Pan D, Tseng Y, Hopfinger AJ. J Chem Inf Comput Sci; 2003 Jul 01; 43(5):1591-607. PubMed ID: 14502494 [Abstract] [Full Text] [Related]
20. Matched molecular pair analysis of activity and properties of glycogen phosphorylase inhibitors. Birch AM, Kenny PW, Simpson I, Whittamore PR. Bioorg Med Chem Lett; 2009 Feb 01; 19(3):850-3. PubMed ID: 19103484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]